Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Treatment Challenges in Severe Eosinophilic Asthma: Differential Response to Anti-IL-5 and Anti-IL-5R Therapy
Agamemnon Bakakos, Νikoletta Ρovina, Petros Bakakos
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 8, pp. 3969-3969
Open Access | Times Cited: 21

Showing 21 citing articles:

Neutrophils in host defense, healing, and hypersensitivity: Dynamic cells within a dynamic host
Marie Siwicki, Paul Kubes
Journal of Allergy and Clinical Immunology (2023) Vol. 151, Iss. 3, pp. 634-655
Closed Access | Times Cited: 29
The regulatory role of eosinophils in viral, bacterial, and fungal infections
Pratibha Gaur, Ilan Zaffran, Tresa George, et al.
Clinical & Experimental Immunology (2022) Vol. 209, Iss. 1, pp. 72-82
Open Access | Times Cited: 25
Eosinophilic Asthma, Phenotypes-Endotypes and Current Biomarkers of Choice
Κonstantinos Porpodis, Ioanna Tsiouprou, Apostolos Apostolopoulos, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 7, pp. 1093-1093
Open Access | Times Cited: 24
Lung IL-13 gene signatures are associated with raised tissue eosinophils in COPD
Karl J. Staples, Jodie Ackland, Sruthymol Lukose, et al.
Respiratory Research (2025) Vol. 26, Iss. 1
Open Access
Tezepelumab improved chronic rhinosinusitis with nasal polyps in a Patient with aspirin exacerbated respiratory disease
Yuga Yamashita, Kosuke Terada, Yuka Kodama, et al.
Respiratory Medicine Case Reports (2024) Vol. 50, pp. 102041-102041
Open Access | Times Cited: 4
Real‐world biologics response and super‐response in the International Severe Asthma Registry cohort
Eve Denton, Mark Hew, Matthew Peters, et al.
Allergy (2024) Vol. 79, Iss. 10, pp. 2700-2716
Open Access | Times Cited: 2
Preclinical development of a long-acting trivalent bispecific nanobody targeting IL-5 for the treatment of eosinophilic asthma
Linlin Ma, Min Zhu, Guanghui Li, et al.
Respiratory Research (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 9
Efficacy and Safety of Mepolizumab in the Management of Severe Eosinophilic Asthma: A Systematic Review
Ibrahim M Dighriri, Anas I Alnughaythir, Amna A Albesisi, et al.
Cureus (2023)
Open Access | Times Cited: 5
Sex-Based Differences in Bronchial Asthma: What Are the Mechanisms behind Them?
Daniela Mokrá, Romana Barošová, Juraj Mokrý
Applied Sciences (2023) Vol. 13, Iss. 4, pp. 2694-2694
Open Access | Times Cited: 4
Exploring redox imbalance and inflammation for asthma therapy
Morayo Barnabas, Oluwakemi Josephine Awakan, Damilare Rotimi, et al.
Molecular Biology Reports (2023) Vol. 50, Iss. 9, pp. 7851-7865
Closed Access | Times Cited: 3
Inflammatory Arthritis and Bone Metabolism Regulated by Type 2 Innate and Adaptive Immunity
Yasunori Omata, Michael Frech, Taku Saito, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1104-1104
Open Access | Times Cited: 5
Asthma severity and corticosteroid response depend on variable type 1 and type 2 inflammation in the airway
John V. Fahy, Nathan D. Jackson, Satria P. Sajuthi, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
The Determinants of Eosinophilia in Patients With Severe Asthma
Racha Abi Melhem, Marc Assaad, Khalil El Gharib, et al.
Journal of Clinical Medicine Research (2024) Vol. 16, Iss. 4, pp. 133-137
Open Access
Immunobiological therapy in the treatment of severe asthma
David Evangelista Barros de Oliveira, Carlos Gustavo Alves Leitão, F Falcão, et al.
Research Society and Development (2024) Vol. 13, Iss. 5, pp. e14513545933-e14513545933
Open Access
Sophora davidii Hance leaves total alkaloids (SDLTAs) alleviate asthma through inhibiting airway inflammation and regulating TLR4/MyD88/c-Jun pathway based on systematic pharmacology and molecular docking
Wenbing Zhi, Xiaoyan Zhang, Zongren Xu, et al.
Journal of Functional Foods (2024) Vol. 122, pp. 106472-106472
Open Access
Understanding Differential Response to Biologic Therapies in Severe Asthma: Retrospective study
Laila Salameh, Fatema Abdulkarim, Maitha Hammadi, et al.
Medical Research Archives (2024) Vol. 12, Iss. 3
Open Access
Efficacy of benralizumab in severe eosinophilic asthma: results of a real clinical practice prospective study BEST in Russia
Daria Fomina, Г. Л. Игнатова, T. G. Kabanova, et al.
PULMONOLOGIYA (2024) Vol. 34, Iss. 3, pp. 441-453
Open Access
Efficacy of benralizumab in severe eosinophilic asthma: an interim analysis of a real clinical practice prospective study BEST in Russia
Daria Fomina, Г. Л. Игнатова, T. G. Kabanova, et al.
PULMONOLOGIYA (2023) Vol. 33, Iss. 3, pp. 374-385
Open Access | Times Cited: 1
The effectiveness of benralizumab in the treatment of the eosinophilic phenotype of severe asthma in real clinical practice
О. Н. Титова, Н. А. Кузубова, D. B. Sklyarova, et al.
PULMONOLOGIYA (2021) Vol. 31, Iss. 5, pp. 628-634
Open Access | Times Cited: 3
A Comparative and Comprehensive Review of Antibody Applications in the Treatment of Lung Disease
Yuefeng Wu, Hai Song
Life (2022) Vol. 12, Iss. 1, pp. 130-130
Open Access | Times Cited: 2
Biologics in severe asthma: Outcomes in clinical trials-Similarities and differences
Agamemnon Bakakos, Νikoletta Ρovina, Stelios Loukides, et al.
Expert Opinion on Biological Therapy (2022) Vol. 22, Iss. 7, pp. 855-870
Closed Access | Times Cited: 2
Page 1

Scroll to top